Skip to content
ETopical – Lifestyle
Home
Sample Page
Author:
Idorsia Pharmaceuticals Ltd
New analysis of Idorsia’s aprocitentan demonstrates significant and sustained reduction in albuminuria in patients with uncontrolled / resistant hypertension
June 1, 2026